Expand ALMR Menu
ALMR MENU

ALMR Latest Press Releases

-- September 1, 2026 --

Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference Globe Newswire 4:05 PM

-- August 10, 2026 --

Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance Globe Newswire 4:05 PM
Alamar Biosciences Expands Global Partnership with Alzheimer's Disease Data Initiative and Gates Ventures Globe Newswire 4:03 PM

-- July 28, 2026 --

Alamar Biosciences Launches NULISAseq Immune 340 Panel for Comprehensive Profiling of the Immune Proteome Globe Newswire 4:12 PM

-- July 14, 2026 --

Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 Globe Newswire 4:05 PM

-- July 13, 2026 --

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases Globe Newswire 2:30 AM

-- July 10, 2026 --

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling Globe Newswire 6:11 AM

-- July 7, 2026 --

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease Research Globe Newswire 9:12 AM

-- June 2, 2026 --

Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics Globe Newswire 8:11 AM

-- May 8, 2026 --

Alamar Biosciences Reports First Quarter 2026 Financial Results Globe Newswire 8:00 AM

-- May 5, 2026 --

Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference Globe Newswire 4:05 PM

-- April 30, 2026 --

Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026 Globe Newswire 4:05 PM

-- April 20, 2026 --

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ PRNewswire 3:10 AM
Market Data Delayed 15 Minutes